Skip to content
10-K

Annual Report

WEST PHARMACEUTICAL SERVICES INC WST

0000105770-26-000010

← back to feed
Filed
Feb 17, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Jan 29, 2026 72.02M sh
Shares Diluted FY 2025 · Dec 31, 2025 72.7M sh
Shares Diluted FY 2025 · Dec 31, 2024 73.7M sh
Shares Diluted FY 2025 · Dec 31, 2023 75.3M sh
Stock Repurchased FY 2025 · Dec 31, 2025 $134M
Stock Repurchased FY 2025 · Dec 31, 2024 $560.9M
Stock Repurchased FY 2025 · Dec 31, 2023 $438.3M
Dividends Paid FY 2025 · Dec 31, 2025 $61.2M
Dividends Paid FY 2025 · Dec 31, 2024 $59.1M
Dividends Paid FY 2025 · Dec 31, 2023 $57M
Capex FY 2025 · Dec 31, 2025 $285.9M
Capex FY 2025 · Dec 31, 2024 $377M
Capex FY 2025 · Dec 31, 2023 $362M
Operating Cash Flow FY 2025 · Dec 31, 2025 $754.8M
Operating Cash Flow FY 2025 · Dec 31, 2024 $653.4M
Operating Cash Flow FY 2025 · Dec 31, 2023 $776.5M
Long Term Debt FY 2025 · Dec 31, 2025 $202.8M
Long Term Debt FY 2025 · Dec 31, 2024 $202.6M
Cash And Equivalents FY 2025 · Dec 31, 2025 $791.3M
Cash And Equivalents FY 2025 · Dec 31, 2024 $484.6M
Stockholders Equity FY 2025 · Dec 31, 2025 $3.18B
Stockholders Equity FY 2025 · Dec 31, 2024 $2.68B
Stockholders Equity FY 2025 · Dec 31, 2023 $2.88B
Stockholders Equity FY 2025 · Dec 31, 2022 $2.68B
Current Liabilities FY 2025 · Dec 31, 2025 $654.9M
Current Liabilities FY 2025 · Dec 31, 2024 $550.4M
Total Liabilities FY 2025 · Dec 31, 2025 $1.09B
Total Liabilities FY 2025 · Dec 31, 2024 $961.1M
Current Assets FY 2025 · Dec 31, 2025 $1.98B
Current Assets FY 2025 · Dec 31, 2024 $1.54B
Total Assets FY 2025 · Dec 31, 2025 $4.27B
Total Assets FY 2025 · Dec 31, 2024 $3.64B
Eps Diluted FY 2025 · Dec 31, 2025 $6.79
Eps Diluted FY 2025 · Dec 31, 2024 $6.69
Eps Diluted FY 2025 · Dec 31, 2023 $7.88
Eps Basic FY 2025 · Dec 31, 2025 $6.83
Eps Basic FY 2025 · Dec 31, 2024 $6.75
Eps Basic FY 2025 · Dec 31, 2023 $7.98
Sga Expense FY 2025 · Dec 31, 2025 $393.6M
Sga Expense FY 2025 · Dec 31, 2024 $338.5M
Sga Expense FY 2025 · Dec 31, 2023 $353.4M
Rd Expense FY 2025 · Dec 31, 2025 $74.3M
Rd Expense FY 2025 · Dec 31, 2024 $69.1M
Rd Expense FY 2025 · Dec 31, 2023 $68.4M
Net Income FY 2025 · Dec 31, 2025 $493.7M
Net Income FY 2025 · Dec 31, 2024 $492.7M
Net Income FY 2025 · Dec 31, 2023 $593.4M
Operating Income FY 2025 · Dec 31, 2025 $584.9M
Operating Income FY 2025 · Dec 31, 2024 $569.9M
Operating Income FY 2025 · Dec 31, 2023 $676M
Gross Profit FY 2025 · Dec 31, 2025 $1.1B
Gross Profit FY 2025 · Dec 31, 2024 $998.5M
Gross Profit FY 2025 · Dec 31, 2023 $1.13B
Cost Of Revenue FY 2025 · Dec 31, 2025 $1.97B
Cost Of Revenue FY 2025 · Dec 31, 2024 $1.89B
Cost Of Revenue FY 2025 · Dec 31, 2023 $1.82B
Revenue FY 2025 · Dec 31, 2025 $3.07B
Revenue FY 2025 · Dec 31, 2024 $2.89B
Revenue FY 2025 · Dec 31, 2023 $2.95B